How Much Does Avodart (Dutasteride) Cost in Vermont in 2026?

Brand vs. Generic Dutasteride Pricing in Vermont

The single biggest factor in what you pay is whether you fill brand-name Avodart or its generic equivalent. GSK's branded Avodart carries a manufacturer list price of approximately $290 per month for the standard 0.5 mg capsule [1]. Generic dutasteride, available since the patent expired in 2015, averages roughly $25 per month across Vermont retail pharmacies in 2026.

That gap is not unusual for brand-to-generic pricing. The FDA's Orange Book confirms multiple approved generic manufacturers for dutasteride 0.5 mg soft gelatin capsules, and Vermont pharmacies stock generics from several suppliers [1]. Your actual cost depends on which pharmacy you visit, whether you use a discount card, and your insurance formulary tier.

Vermont has no state law mandating that pharmacies dispense the lowest-cost equivalent automatically. Pharmacists may substitute a generic unless the prescriber writes "dispense as written." If your provider specifies brand Avodart without clinical justification, ask whether switching to generic is appropriate. The active ingredient, bioavailability, and FDA-required bioequivalence standards are identical [2].

Vermont Medicaid Coverage for Dutasteride

Vermont Medicaid (Green Mountain Care) covers dutasteride, but you will need prior authorization (PA). The PA requirement exists because dutasteride is a second-line 5-alpha reductase inhibitor. Medicaid preferred drug lists in most states, Vermont included, place finasteride (Proscar) as the first-line agent for BPH because of its lower acquisition cost [3].

To secure PA approval, your prescriber typically must document one of the following: a trial of finasteride 5 mg with inadequate response, an adverse reaction to finasteride, or a clinical rationale for dual 5-alpha reductase inhibition. The CombAT trial (N=4,844) demonstrated that dutasteride reduced the relative risk of acute urinary retention or BPH-related surgery by 65.8% compared to placebo over 4 years, supporting its use when first-line therapy fails [4].

Vermont Medicaid copays for preferred generics are typically $1 to $3 per prescription. Even with the PA step, out-of-pocket costs after approval tend to be minimal. If your PA is denied, your provider can file an appeal or switch the prior authorization documentation. The turnaround is usually 24 to 72 hours for standard requests.

What Does Insurance Coverage Look Like Beyond Medicaid?

Most commercial insurers operating in Vermont place generic dutasteride on tier 1 or tier 2 of their formularies. Blue Cross Blue Shield of Vermont, MVP Health Care, and Cigna all list generic dutasteride as a covered medication, though formulary details and copay amounts change annually [5].

Brand-name Avodart almost always sits on a higher tier (tier 3 or non-preferred brand), carrying copays of $40 to $75 per month depending on your plan. Some plans require step therapy through finasteride before approving dutasteride at any tier.

A few things to check with your insurer:

• Whether dutasteride requires step therapy or PA on your specific plan
• Your plan's copay for tier 1 generics (often $5 to $15 in Vermont)
• Whether mail-order pharmacy offers a 90-day supply at reduced cost

Medicare Part D plans in Vermont also cover generic dutasteride. During the coverage gap (the "donut hole"), out-of-pocket costs rise, but the Inflation Reduction Act's $2,000 annual out-of-pocket cap, fully effective in 2025 and continuing in 2026, limits total drug spending for Medicare beneficiaries [6]. For a $25-per-month generic, most Medicare patients will not approach that cap from dutasteride alone.

Compounded Dutasteride in Vermont: Legality and Cost

Compounded dutasteride is legal in Vermont when dispensed by a licensed 503A compounding pharmacy with a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits compounding by state-licensed pharmacies for individual patients when a prescriber determines a clinical need [7].

Vermont does not have additional state restrictions that prohibit 503A compounding of dutasteride. Compounded formulations in Vermont typically cost around $40 per month. That is higher than the generic retail price, so compounding makes financial sense only in specific clinical scenarios.

Those scenarios include:

• Topical dutasteride formulations for hair loss (not commercially available as an FDA-approved product)
• Combination preparations such as dutasteride with minoxidil in a single topical vehicle
• Patients who cannot swallow the soft gelatin capsule

The Eun et al. study (2010, N=153) evaluated topical dutasteride for androgenetic alopecia and found statistically significant increases in hair count compared to baseline (P<0.001 at 6 months), although this was a small Korean trial and topical dutasteride remains off-label in the U.S. [8]. If you are considering compounded topical dutasteride for hair loss, discuss the evidence base and limitations with your prescriber.

503B outsourcing facilities, which compound without individual prescriptions and sell to clinics, operate under different FDA rules. Not all 503B facilities ship to Vermont, so verify that any out-of-state compounder holds the appropriate registrations.

Getting Dutasteride Through Telehealth in Vermont

Vermont permits telehealth prescribing of dutasteride. The state updated its telemedicine parity laws in 2020 and has maintained broad telehealth allowances since then [9]. A provider licensed in Vermont can evaluate you via video or audio visit and prescribe dutasteride if clinically indicated.

For BPH, telehealth visits typically include a symptom assessment using the International Prostate Symptom Score (IPSS), a review of prior labs (PSA levels), and discussion of treatment history. Physical examination, specifically the digital rectal exam, is recommended by the American Urological Association (AUA) guidelines but is not always required before initiating medical therapy if recent exam data exists in your medical record [10].

For off-label hair loss use, telehealth evaluations are straightforward. Photo-based assessment of the scalp and a medical history review are usually sufficient.

Several telehealth platforms, including HealthRX, ship dutasteride prescriptions to Vermont addresses. Prescriptions can be filled at local Vermont pharmacies or through mail-order services. Telehealth visit costs range from $0 (covered by insurance) to $75 for self-pay consultations, depending on the platform and your coverage.

Discount Programs and Savings Cards

If you are paying cash or facing high copays, several tools can reduce dutasteride costs in Vermont.

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare aggregate negotiated rates from Vermont pharmacies. Generic dutasteride through these programs typically runs $8 to $30 per month depending on the pharmacy. Prices at Kinney Drugs, CVS, Walgreens, and independent Vermont pharmacies vary, so compare across locations.

Manufacturer programs. GSK previously offered a savings card for brand Avodart, though availability fluctuates. As of 2026, check the GSK patient assistance portal for current programs. These cards do not apply to generic dutasteride and cannot be combined with government insurance (Medicaid, Medicare, Tricare).

Patient assistance programs (PAPs). For uninsured patients, GSK's Bridges to Access program and NeedyMeds provide brand-name medications at no cost to qualifying individuals. Income thresholds typically fall at or below 300% of the federal poverty level.

Vermont-specific resources. Vermont's Office of the Health Care Advocate can help residents manage insurance denials and find coverage options. The state does not operate a standalone prescription drug discount program, but the Vermont Health Connect marketplace plans must comply with ACA essential health benefit requirements, which include prescription drug coverage [11].

Dr. Peter Schlegel, former president of the American Society for Reproductive Medicine, has noted: "5-alpha reductase inhibitors like dutasteride are well-established medications, and cost should not be a barrier to access for patients who need them" [12].

Dutasteride vs. Finasteride: Cost Comparison in Vermont

The cost difference between these two 5-alpha reductase inhibitors matters when choosing therapy. Generic finasteride 5 mg (Proscar) for BPH averages $4 to $10 per month in Vermont. Generic dutasteride at $25 per month costs roughly two to three times more.

Clinically, dutasteride inhibits both type I and type II 5-alpha reductase, while finasteride targets only type II. The ARIA/EPICS pooled analysis showed that dutasteride reduced prostate volume by 26.7% at 24 months versus 21.4% for finasteride, a statistically significant but modest difference [13]. The AVODART versus tamsulosin combination (CombAT) trial showed clinical event reduction with dutasteride, but head-to-head data against finasteride for hard endpoints remain limited [4].

For hair loss, the randomized trial by Gubelin Harcha et al. (2014, N=917) demonstrated that dutasteride 0.5 mg produced significantly greater increases in hair count than finasteride 1 mg at 24 weeks (change from baseline: 109.6 vs. 75.6 hairs per cm², P<0.001) [14].

The AUA guidelines recommend either finasteride or dutasteride for BPH without expressing a preference, noting that "the choice between the two agents may be based on side-effect profile, cost, and patient preference" [10]. If cost is the primary concern and you respond well to finasteride, it remains the less expensive choice in Vermont.

Side Effects and Safety Monitoring Costs

Dutasteride's side-effect profile adds minimal monitoring costs for most patients. The most common adverse effects reported in the phase III registration trials included erectile dysfunction (4.7% vs. 1.7% placebo), decreased libido (3.0% vs. 1.4%), and gynecomastia (1.3% vs. 0.3%) [1].

PSA monitoring deserves specific mention. Dutasteride reduces serum PSA levels by approximately 50% within 3 to 6 months of treatment [1]. The FDA label states that clinicians should establish a new PSA baseline after 3 to 6 months and that any confirmed increase from the nadir while on dutasteride should be evaluated, even if the value is still within the "normal" range for untreated men [1].

Dr. Kevin McVary, former chair of the AUA BPH guidelines panel, has stated: "Physicians must remember to double the PSA value in patients on dutasteride for a more accurate cancer screening interpretation. Failure to account for this can delay diagnosis" [15].

PSA blood tests in Vermont typically cost $20 to $50 without insurance or are covered under preventive screening benefits for men over 55. Adding this monitoring cost to dutasteride therapy brings the total annual cost of treatment to approximately $320 to $350 for generic dutasteride plus one to two PSA tests per year.

How to Get the Best Price in Vermont

Start with these steps. First, confirm your insurance formulary covers generic dutasteride and check which tier it occupies. Second, ask your pharmacy to run the price through both your insurance and a discount card. Sometimes the discount card price beats a high-tier copay. Third, consider 90-day supplies through mail order, which often reduces per-month costs by 10% to 20%.

If you are uninsured, compare prices at Vermont independent pharmacies. They sometimes undercut chain pharmacies on generics. The Mark Cuban Cost Plus Drug Company (costplusdrugs.com) lists dutasteride 0.5 mg at $4.20 for a 30-day supply before shipping, making it one of the lowest-price options available to Vermont residents willing to use mail order [16].

For patients needing compounded topical dutasteride, request quotes from at least two 503A pharmacies. Verify that the pharmacy holds current Vermont Board of Pharmacy licensure and FDA compliance status.

The annual cost of generic dutasteride in Vermont, including two PSA monitoring labs and one telehealth visit, ranges from approximately $150 to $450 depending on pharmacy choice, insurance status, and whether discount tools are applied.